FDA Initiates Probe into Possible Hip Replacement Metal Poisoning
The FDA has ordered 21 hip implant manufacturers to conduct further studies into metal poisoning.
Breaking Class Action News & Legal Updates
Yaz Blood Clot Risk Being Investigated by FDA
Yaz blood clot risk being investigated by the FDA to determine if there is heightened risk of blood clots in patients taking Yaz, Yasmin or Ocella.
Uponor Lawsuit May be Viable Due to Failing Plumbing Fittings
Uponor Lawsuit: Uponor class action lawsuit may be an option for homeowners with low water pressure, failing plumbing fittings and leaking plumbing.
Metanx, Medical Food Generics May Not Be Equivalent
Metanx generics and substitutes for medical foods may not be therapeutically equivalent to the branded prescription product.
Avandia Banned in U.S. Pharmacies
The FDA has banned Avandia in pharmacies due to Avandia heart risks, including stroke and heart failure.
Pregnant Zoloft Users Likely To Deliver Children with Birth Defects
Zoloft birth defects: A report finds that women taking Zoloft during pregnancy are twice as likely to deliver a child with a Zoloft birth defect.
Zimmer Knee Failure Rate May Be as High as 9%
Zimmer Knee Implant Failures: The Zimmer NexGen CR-Flex may fail at a rate of 9.3%, says one study.
SSRI Users May Still Experience Depression Symptoms: Study
SSRI Side Effects: Study shows that SRRIs, including Celexa, Lexapro, and Zoloft, may still leave users with depression symptoms.
Topamax Recall Issued Due to Foul Odor
Topamax Recall: A recall of Topamax has been issued due to a foul odor, and not due to the risk of Topamax birth defects.
Women Implanted with Recalled DePuy Hips More Likely to Need Revision
DePuy Hip Recall: Women implanted with recalled DePuy ASR hips are more likely than men to need revision surgery for their DePuy hip problems.